1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INFINITY PHARMACEUTICALS INC.

Infinity Pharmaceuticals Inc.

XNAS: INFI

Watchlist

Portfolio

Share


Insider Trading disclosures for Infinity Pharmaceuticals Inc.

The latest disclosure was made by Stephane Peluso in Infinity Pharmaceuticals Inc. where a trade of 50,000 Common Stock done was reported to US exchanges on Aug. 2, 2022.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stephane Peluso Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2022 50,000 52,046 (0%) 0% - Common Stock
Stephane Peluso Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2022 50,000 0 - - Restricted Stock Unit
Stephane Peluso Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.66 per share. 02 Aug 2022 14,994 37,052 (0%) 0% 0.7 9,932 Common Stock
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option(right to buy)
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.68 per share. 16 Jun 2022 46,378 215,403 (0%) 0% 0.7 31,491 Common Stock
Brian Eric Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option(right to buy)
Brian Eric Schwartz Director Grant, award, or other acquisition of securities at price $ 0.68 per share. 16 Jun 2022 30,919 30,919 (0%) 0% 0.7 20,994 Common Stock
David William Beier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option (right to buy)
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 10,000 10,000 - - Stock Option(right to buy)
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option(right to buy)
Richard B. Gaynor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option(right to buy)
Samuel Agresta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 45,000 45,000 - - Stock Option(right to buy)
Sujay R. Kango Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2022 90,000 90,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2022 335,000 335,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2022 576,100 576,100 - - Stock Option (right to buy)
Seth A. Tasker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2022 225,000 225,000 - - Stock Option (right to buy)
Stephane Peluso Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2022 87,027 87,027 - - Stock Option(right to buy)
Robert Ilaria Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2022 87,472 87,472 - - Stock Option(right to buy)
Brian Eric Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2021 60,000 60,000 - - Stock Option (right to buy)
Stephane Peluso Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 50,000 50,000 - - Restricted Stock Unit
Stephane Peluso Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 250,000 250,000 - - Stock Options (right to buy)
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 3.43 per share. 10 Jun 2021 3,061 169,025 (0%) 0% 3.4 10,499 Common Stock
David William Beier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
David William Beier Director Grant, award, or other acquisition of securities at price $ 3.43 per share. 10 Jun 2021 3,061 8,775 (0%) 0% 3.4 10,499 Common Stock
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (right to buy)
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Richard Gaynor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Samuel Agresta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Norman C. Selby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.92 per share. 14 May 2021 5,000 15,000 (0%) 0% 0.9 4,600 Common Stock
Norman C. Selby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2021 5,000 35,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 335,000 335,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 485,000 485,000 - - Stock Option (right to buy)
Seth A. Tasker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 250,000 250,000 - - Stock Option (right to buy)
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 22,826 165,964 (0%) 0% 0 Common Stock
Anthony B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Michael C. Venuti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
David William Beier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Norman C. Selby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 10,000 10,000 - - Stock Option (right to buy)
Samuel Agresta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Richard Gaynor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 60,000 60,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 83,157 745,094 (1%) 0% 0 Common Stock
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 418,750 418,750 - - Stock Option (right to buy)
Adelene Q. Perkins Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 155,134 793,190 (1%) 0% 0 Common Stock
Adelene Q. Perkins Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 606,250 606,250 - - Stock Option (right to buy)
Seth A. Tasker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 412,500 412,500 - - Stock Option (right to buy)
Seth A. Tasker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 53,538 101,364 (0%) 0% 0 Common Stock
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 450,000 450,000 - - Stock Option (right to buy)
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 64,219 77,376 (0%) 0% 0 Common Stock
Samuel Agresta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Oct 2019 60,000 60,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 1.60 per share. 13 Jun 2019 13,125 143,138 (0%) 0% 1.6 21,000 Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 30,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 100,000 100,000 - - Stock Option (right to buy)
Michael G. Kauffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 30,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 30,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 242,000 242,000 - - Stock Option (right to buy)
David William Beier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 30,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 10,000 0 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 0 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 30,000 30,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 1.60 per share. 13 Jun 2019 26,250 85,238 (0%) 0% 1.6 42,000 Common Stock
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2019 335,000 335,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2019 243,000 243,000 - - Stock Option (right to buy)
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2019 140,000 140,000 - - Stock Option (right to buy)
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2019 155,000 155,000 - - Stock Option (right to buy)
Samuel Agresta Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2019 62,596 62,596 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.82 per share. 01 Oct 2018 5,000 609,561 (1%) 0% 2.8 14,100 Common Stock
Jeffery Kutok Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.01 per share. 15 Aug 2018 8,180 6,133 (0%) 0% 2.0 16,421 Common Stock
Jeffery Kutok Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.00 per share. 15 Aug 2018 6,133 0 (0%) 0% 2 12,266 Common Stock
Samuel Agresta Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2018 300,000 300,000 - - Stock Option (right to buy)
Jeffery Kutok Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.00 per share. 22 Jun 2018 14,313 14,313 (0%) 0% 2.0 28,695 Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 2,000 2,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 1.75 per share. 12 Jun 2018 11,428 130,013 (0%) 0% 1.8 19,999 Common Stock
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 4,000 4,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 1.75 per share. 12 Jun 2018 22,857 45,845 (0%) 0% 1.8 40,000 Common Stock
Michael G. Kauffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 4,000 4,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
David William Beier None Grant, award, or other acquisition of securities at price $ 1.75 per share. 12 Jun 2018 5,714 5,714 (0%) 0% 1.8 10,000 Common Stock
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 2,000 2,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 10,000 10,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2018 20,000 20,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 1.75 per share. 12 Jun 2018 22,857 58,988 (0%) 0% 1.8 40,000 Common Stock
David William Beier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2018 40,000 40,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.78 per share. 05 Mar 2018 5,000 607,252 (1%) 0% 2.8 13,890 Common Stock
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 500,000 500,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 37,881 626,133 (1%) 0% 0 Common Stock
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 100,000 100,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 69,924 612,252 (1%) 0% 0 Common Stock
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 180,000 180,000 - - Stock Option (right to buy)
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 22,351 41,284 (0%) 0% 0 Common Stock
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 65,000 65,000 - - Stock Option (right to buy)
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 28,626 28,626 (0%) 0% 0 Common Stock
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 70,000 70,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Purchase of securities on an exchange or from another person at price $ 1.81 per share. 06 Dec 2017 500,000 580,944 (1%) 0% 1.8 905,000 Common Stock
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2017 39,039 80,944 (0%) 0% 0 Common Stock
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2017 85,800 535,020 (1%) 0% 0 Common Stock
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2017 8,916 17,833 (0%) 0% 0 Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 2,000 2,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 1.74 per share. 25 May 2017 11,494 118,585 (0%) 0% 1.7 20,000 Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 20,000 20,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 4,000 4,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 1.74 per share. 25 May 2017 22,988 22,988 (0%) 0% 1.7 39,999 Common Stock
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 20,000 20,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 250,000 250,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 4,000 4,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 20,000 20,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 10,000 10,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 2,000 2,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 20,000 20,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 1.74 per share. 25 May 2017 5,747 36,131 (0%) 0% 1.7 10,000 Common Stock
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 20,000 20,000 - - Stock Option (right to buy)
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 150,000 150,000 - - Stock Option (right to buy)
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 125,000 125,000 - - Stock Option (right to buy)
Michael G. Kauffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2017 40,000 40,000 - - Stock Option(right to buy)
Michael C. Venuti None Sale of securities on an exchange or to another person at price $ 3.48 per share. 17 Mar 2017 6,250 50,000 (0%) 0% 3.5 21,750 Common Stock
Jeffery Kutok Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2017 250,000 250,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Lawrence E. Bloch President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 500,000 500,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 1,000,000 1,000,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Jose Baselga None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 40,000 40,000 - - Stock Option (right to buy)
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 250,000 250,000 - - Stock Option (right to buy)
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Dec 2016 401,726 3,627,610 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Dec 2016 260,046 2,334,644 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Dec 2016 77,076 698,623 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Dec 2016 2,348 3,629,958 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Dec 2016 1,205 2,335,849 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 236,393 3,106,036 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 150,451 1,997,446 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 47,812 598,282 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 108,202 3,214,238 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 69,041 2,066,487 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 21,021 619,303 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 11,646 3,225,884 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 8,111 2,074,598 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2016 2,244 621,547 - - Common Stock, $0.001 par value
Sujay Kango Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 25,009 50,590 - - Common Stock
Sujay Kango Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 298 50,292 - - Common Stock
Sujay Kango Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 42,017 8,275 - - Common Stock
Sujay Kango Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 7,676 599 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 81,276 2,838,645 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 52,457 1,828,409 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 15,161 547,554 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 30,998 2,869,643 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 18,586 1,846,995 - - Common Stock, $0.001 par value
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2016 2,916 550,470 - - Common Stock, $0.001 par value
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 39,039 41,905 - - Common Stock
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 59,150 59,150 - - Common Stock
Adelene Q. Perkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 85,800 449,220 - - Common Stock
Sujay Kango Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 75,000 75,599 - - Common Stock
Seth A. Tasker General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,917 8,917 - - Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 2,000 2,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 13,157 107,091 - - Common Stock
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 4,000 4,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option(right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 10,000 10,000 - - Stock Option(right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 2,000 2,000 - - Stock Option(right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option(right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 4,000 4,000 - - Stock Option(right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option(right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 6,578 80,319 - - Common Stock
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option(right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 26,315 30,384 - - Common Stock
Jose Baselga None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 20,000 20,000 - - Stock Option(right to buy)
Christopher M. Lindblom Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2016 40,000 40,000 - - Stock Option (right to buy)
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2016 70,000 70,000 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2016 80,000 80,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2016 185,000 185,000 - - Stock Option (right to buy)
Sujay Kango Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2016 60,000 60,000 - - Stock Option (right to buy)
William C. Bertrand General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2015 200,000 200,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2015 2,034 93,934 - - Common Stock
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2015 2,034 73,741 - - Common Stock
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2015 4,069 4,069 - - Common Stock
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Jun 2015 5,000 359,432 - - Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 2,000 2,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 4,000 4,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 10,000 10,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 2,000 2,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 4,000 4,000 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2015 4,737 868 - - Common Stock
Gwen Fyfe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Jose Baselga None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 15,000 15,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 May 2015 10,000 364,432 - - Common Stock
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 May 2015 10,000 374,432 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2015 4,737 5,605 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2015 4,737 0 - - Stock Option (right to buy)
Winston K.C. Lam General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2015 200,000 200,000 - - Stock Option (right to buy)
Sujay Kango Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2015 200,000 200,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2015 20,000 384,432 - - Common Stock
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 25,000 404,432 - - Common Stock
Adelene Q. Perkins Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Jan 2015 20,000 429,432 - - Common Stock
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2015 125,000 125,000 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2015 125,000 125,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2015 250,000 250,000 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2015 85,000 85,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2015 85,000 85,000 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2014 4,737 0 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2014 4,737 4,737 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Dec 2014 4,737 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2014 4,736 4,736 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Nov 2014 4,736 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2014 4,736 0 - - Stock Option (right to buy)
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 7,500 90,900 - - Common Stock
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 6,000 73,400 - - Common Stock
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 10,000 0 - - Stock Option (Right to Buy)
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 10,000 83,400 - - Common Stock
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 1,000 91,900 - - Common Stock
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 1,000 1,000 - - Stock Option (Right to Buy)
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 7,500 7,500 - - Stock Option (Right to Buy)
Anthony B. Evnin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2014 6,000 0 - - Stock Option (Right to Buy)
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Sep 2014 112,451 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 2,367 0 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2014 9,472 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 2,367 9,472 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 7,105 0 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 7,105 7,105 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jun 2014 879 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2014 879 879 - - Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 2,000 2,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 4,000 4,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 10,000 10,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 2,000 2,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 4,000 4,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Gwen Fyfe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 15,000 15,000 - - Stock Option (right to buy)
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2014 2,500 2,500 - - Stock Option (Right to Buy)
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2014 2,500 10,000 - - Common Stock
Jeffrey Berkowitz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 30,000 30,000 - - Stock Option (right to buy)
Jose Baselga None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 30,000 30,000 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2014 4,736 4,736 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Feb 2014 4,736 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Feb 2014 4,736 0 - - Stock Option (right to buy)
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 32,200 32,200 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 56,900 56,900 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 85,500 85,500 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 32,200 32,200 - - Stock Option (right to buy)
Pedro Santabarbara Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 16,600 16,600 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2014 753 753 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jan 2014 753 0 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Dec 2013 17,756 112,451 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Nov 2013 1,200 130,207 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Nov 2013 23,703 270,368 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Nov 2013 138,961 131,407 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2013 4,736 4,736 - - Common Stock
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Sep 2013 4,736 0 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2013 4,736 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 31,924 460,611 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 13,076 447,535 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2013 22,103 23,150 - - Common Stock
Vito J. Palombella Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2013 22,103 0 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Jun 2013 23,150 0 - - Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 2,000 2,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 4,000 4,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 10,000 10,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 2,000 2,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 4,000 4,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Thomas J. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Gwen Fyfe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2013 15,000 15,000 - - Stock Option (right to buy)
Michael C. Venuti None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2013 6,250 0 - - Stock Option (Right to Buy)
Michael C. Venuti None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2013 6,250 56,250 - - Common Stock
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 32,800 32,800 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 101,780 101,780 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 153,835 153,835 - - Stock Option (right to buy)
Christopher M. Lindblom See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 14,941 14,941 - - Stock Option (right to buy)
Joshua Hamermesh VP, Business & Corporate Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 14,940 14,940 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 65,600 65,600 - - Stock Option (right to buy)
Winselow S. Tucker Vice President, Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 22,410 22,410 - - Stock Option (right to buy)
Pedro Santabarbara Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2013 43,735 43,735 - - Stock Option (right to buy)
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2012 2,500 2,500 - - Stock Option (right to buy)
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2012 2,500 7,500 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 22,103 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 331 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 29,432 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 10,204 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 13,927 0 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 23,070 340,930 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 76,930 83,620 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 22,103 338,641 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 331 338,972 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 29,432 368,404 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 10,204 378,608 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 13,927 392,535 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 23,070 415,605 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2012 76,930 492,535 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 17,648 298,903 - - Common Stock
Anthony B. Evnin None Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 4,832 294,071 - - Common Stock
Anthony B. Evnin None Other type of transaction at price $ 0.00 per share. 26 Nov 2012 8,743 67,400 - - Common Stock
Christopher M. Lindblom See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2012 10,000 10,000 - - Stock Option (right to buy)
Christopher M. Lindblom See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2012 3,885 0 - - Stock Option (right to buy)
Christopher M. Lindblom See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2012 10,000 10,000 - - Common Stock
Christopher M. Lindblom See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2012 3,885 13,885 - - Common Stock
Christopher M. Lindblom See Remarks Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Nov 2012 13,885 0 - - Common Stock
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2012 5,000 5,000 - - Stock Option (Right to Buy)
Norman C. Selby None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2012 5,000 5,000 - - Common Stock
Pedro Santabarbara Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Sep 2012 9,200 150,800 - - Stock Option (Right to Buy)
Pedro Santabarbara Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Sep 2012 9,200 9,200 - - Common Stock
Lawrence E. Bloch EVP, CFO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2012 200,000 200,000 - - Stock Option (right to buy)
Steven H. Holtzman None Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 May 2012 57,573 0 - - Common Stock
Steven H. Holtzman None Gift of securities by or to the insider at price $ 0.00 per share. 29 May 2012 15,000 257,834 - - Common Stock
Steven H. Holtzman None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 May 2012 189,303 68,531 - - Common Stock
Steven H. Holtzman None Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 May 2012 10,958 57,573 - - Common Stock
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 10,000 10,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 4,000 4,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 12,000 12,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 4,000 4,000 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 2,000 2,000 - - Stock Option (right to buy)
Thomas J. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Gwen Fyfe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2012 6,000 6,000 - - Stock Option (right to buy)
Norman C. Selby None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2012 10,000 10,000 - - Stock Option (right to buy)
Gwen Fyfe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2012 10,000 10,000 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 126,850 126,850 - - Stock Option (right to buy)
Adelene Q. Perkins Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 191,750 191,750 - - Stock Option (right to buy)
Christopher M. Lindblom See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 30,104 30,104 - - Stock Option (right to buy)
Joshua Hamermesh See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 11,844 11,844 - - Stock Option (right to buy)
Gerald E. Quirk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 40,000 40,000 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 47,136 47,136 - - Stock Option (right to buy)
Winselow S. Tucker VP, Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 30,104 30,104 - - Stock Option (right to buy)
Pedro Santabarbara Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2012 47,136 47,136 - - Stock Option (right to buy)
Arnold J. Levine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 10,000 10,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 4,000 4,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 12,000 12,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 4,000 4,000 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
James B. Tananbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 2,000 2,000 - - Stock Option (right to buy)
Thomas J. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2011 6,000 6,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 120,000 120,000 - - Stock Option (right to buy)
Julian Adams President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 106,210 106,210 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 160,550 160,550 - - Stock Option (right to buy)
Christopher M. Lindblom Controller & Asst. Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 9,828 9,828 - - Stock Option (right to buy)
Gerald E. Quirk VP,Cor. Affairs & Gnrl Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 9,828 9,828 - - Stock Option (right to buy)
Vito J. Palombella Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 39,520 39,520 - - Stock Option (right to buy)
Winselow S. Tucker Vice President, Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2011 6,552 6,552 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2010 809 316,538 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2010 10,000 315,729 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2010 14,191 305,729 - - Common Stock
Steven H. Holtzman Director, Exec Chair of the Board of Dir Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2010 100,000 275,535 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2010 44,651 286,189 - - Common Stock
Adelene Q. Perkins Director, Pres & Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2010 5,349 291,538 - - Common Stock
Christopher M. Lindblom Controller & Asst. Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2010 27,000 27,000 - - Stock Option (right to buy)
Arnold J. Levine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 9,375 9,375 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 3,750 3,750 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 3,750 3,750 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
James B. Tananbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Franklin H. Moss None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 1,875 1,875 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Thomas J. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 5,625 5,625 - - Stock Option (right to buy)
Winselow S. Tucker Vice President, Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 75,000 75,000 - - Stock Option (right to buy)
Steven H. Holtzman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 156,000 156,000 - - Stock Option (right to buy)
Julian Adams President of R&D and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 104,000 104,000 - - Stock Option (right to buy)
Adelene Q. Perkins Director, Pres & Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 364,000 364,000 - - Stock Option (right to buy)
Christopher M. Lindblom Controller & Asst. Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 9,238 9,238 - - Stock Option (right to buy)
Tong K Jeffrey VP, Cor. & Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 15,440 15,440 - - Stock Option (right to buy)
Gerald E. Quirk VP,Cor. Affairs & Gnrl Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2010 25,440 25,440 - - Stock Option (right to buy)
Thomas J. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2009 9,375 9,375 - - Stock Option (right to buy)
Arnold J. Levine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 9,375 9,375 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 3,750 3,750 - - Stock Option (right to buy)
Harry F. Hixson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 3,750 3,750 - - Stock Option (right to buy)
Eric S. Lander None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
James B. Tananbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Franklin H. Moss None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 5,625 5,625 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2009 1,875 1,875 - - Stock Option (right to buy)
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 5,499 1,118,257 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 568,663 549,594 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 18,331 531,263 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 278,648 252,615 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 77,728 174,887 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 152,889 21,998 - - Common Stock
Patrick P. Lee None Other type of transaction at price $ 0.00 per share. 19 Feb 2009 21,998 0 - - Common Stock
Steven H. Holtzman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2009 80,000 80,000 - - Stock Option (right to buy)
Julian Adams President of R&D and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2009 50,000 50,000 - - Stock Option (right to buy)
Adelene Q. Perkins Pres & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2009 50,000 50,000 - - Stock Option (right to buy)
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 600 232,938 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 100 233,038 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 420 233,458 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 2,000 235,458 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 198 235,656 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 239 235,895 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 100 235,995 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 1,000 236,995 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 1,043 238,038 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 100 238,138 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 1,000 239,138 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 200 239,338 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 100 239,438 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Dec 2008 2,100 241,538 - - Common Stock
Steven H. Holtzman Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2008 160,000 160,000 - - Stock Option (right to buy)
Julian Adams Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2008 110,000 110,000 - - Stock Option (right to buy)
Adelene Q. Perkins Pres & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2008 110,000 110,000 - - Stock Option (right to buy)
Adelene Q. Perkins Pres & Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2008 130,000 130,000 - - Stock Option (right to buy)
Christopher M. Lindblom Assistant Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2008 7,555 7,555 - - Stock Option (right to buy)
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 5,700 215,997 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 4,300 220,297 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 8,941 229,238 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 1,820 231,058 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 1,180 232,238 - - Common Stock
Adelene Q. Perkins Pres & Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2008 100 232,338 - - Common Stock
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 54,727 0 - - Stock Option (right to buy)
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 54,727 0 - - Stock Option (right to buy)
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 331 0 - - Stock Option (right to buy)
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 27,628 0 - - Stock Option (right to buy)
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 54,727 180,257 - - Common Stock
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 54,727 234,984 - - Common Stock
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 331 235,315 - - Common Stock
Julian Adams President, R&D & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2008 27,628 262,943 - - Common Stock
Steven H. Holtzman Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2008 33,154 345,668 - - Common Stock
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2008 3,750 3,750 - - Stock Option (right to buy)
Steven H. Holtzman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Aug 2008 22,103 256,926 - - Common Stock
Christopher M. Lindblom Assistant Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2008 15,000 15,000 - - Stock Option (Right to Buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 9,375 9,375 - - Stock Option (Right to Buy)
Michael C. Venuti None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 3,750 3,750 - - Stock Option (right to buy)
Vicki L. Sato None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 1,875 1,875 - - Stock Option (right to buy)
Ian F. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 9,375 9,375 - - Stock Option (right to buy)
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 3,750 3,750 - - Stock Option (right to buy)
Martin Babler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2008 9,375 9,375 - - Stock Option (right to buy)
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Mar 2008 426 209,947 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Mar 2008 300 210,247 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Mar 2008 50 210,297 - - Common Stock
Patrick P. Lee None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2008 3,750 3,750 - - Stock Option (Right to Buy)
Steven H. Holtzman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2007 167,000 167,000 - - Stock Option (Right to Buy)
Julian Adams President, R&D & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2007 111,200 111,200 - - Stock Option (Right to Buy)
Adelene Q. Perkins EVP and Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2007 128,000 128,000 - - Stock Option (Right to Buy)
Christopher M. Lindblom Assistant Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2007 3,885 3,885 - - Stock Option (Right to Buy)
Steven H. Holtzman Director, Chairman and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Sep 2007 5,000 234,823 - - Common Stock
Arnold J. Levine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2007 3,750 3,750 - - Stock Option (right to buy)
Anthony B. Evnin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2007 1,875 1,875 - - Stock Option (Right to Buy)
Herm Rosenman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2007 3,750 3,750 - - Stock Option (right to buy)
Vicki L. Sato None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2007 9,375 9,375 - - Stock Option (right to buy)
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Jun 2007 1,000 200,521 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Jun 2007 1,000 201,521 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Jun 2007 8,000 209,521 - - Common Stock
D. Ronald Daniel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2007 1,875 1,875 - - Stock Option (right to buy)
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 1,000 194,075 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 2,200 196,275 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 200 196,475 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 100 196,575 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 100 196,675 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 200 196,875 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 100 196,975 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 646 197,621 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 200 197,821 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 100 197,921 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 100 198,021 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 May 2007 1,500 199,521 - - Common Stock
Adelene Q. Perkins EVP and Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 May 2007 700 178,627 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters